StockData
ImmuCell Corp logo

ImmuCell Corp (ICCC) stock

ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/303% above fair value
$11.33−0.09 (-0.79%)

Close on Nov 17, 2026Market cap $102.90MP/E 141.6Yield –

ImmuCell enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

ImmuCell's enterprise value was $91.99M on Nov 11, 2026, against $49.39M a year earlier. Over the last 5 years it ranged from $33.86M to $103.30M, with a median of $54.19M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$91.99M+50.2%
2025Dec 31, 2025$61.24M+16.5%
2024Dec 31, 2024$52.58M+5.7%
2023Dec 29, 2023$49.76M+29.5%
2022Dec 30, 2022$38.43M-25.3%
2021Dec 31, 2021$51.44M+10.0%
2020Dec 31, 2020$46.76M+28.8%
2019Dec 31, 2019$36.31M-20.8%
2018Dec 31, 2018$45.85M+8.9%
2017Dec 29, 2017$42.10M+209.6%
2016Dec 30, 2016$13.60M-21.9%
2015Dec 31, 2015$17.40M+62.1%
2014Dec 31, 2014$10.74M+43.1%
2013Dec 31, 2013$7.51M+1.0%
2012Dec 31, 2012$7.43M-18.2%
2011Dec 30, 2011$9.09M+7.0%
2010Dec 31, 2010$8.49M–

More ImmuCell figures

See a number that looks wrong?